Publikationen in Zusammenarbeit mit Forschern von Medical University of Vienna (17)

2024

  1. A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort

    Schizophrenia Research, Vol. 266, pp. 237-248

  2. PsyCog: A computerised mini battery for assessing cognition in psychosis

    Schizophrenia Research: Cognition, Vol. 37

2023

  1. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations

    Nature genetics, Vol. 55, Núm. 3, pp. 369-376

2022

  1. Clinical decision-making style preferences of European psychiatrists: Results from the Ambassadors survey in 38 countries

    European Psychiatry, Vol. 65, Núm. 1

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2021

  1. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543

  2. Dalbavancin for the treatment of prosthetic joint infections: A narrative review

    Antibiotics, Vol. 10, Núm. 6

  3. Pre-training inter-rater reliability of clinical instruments in an international psychosis research project

    Schizophrenia Research

  4. Reconceptualising treatment-resistant depression as difficult-to-treat depression

    The Lancet Psychiatry

2020

  1. Combined MEK and PI3K/p110β inhibition as a novel targeted therapy for malignant mesothelioma displaying sarcomatoid features

    Cancer Research, Vol. 80, Núm. 4, pp. 843-856

  2. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases

    British Journal of Dermatology, Vol. 183, Núm. 4, pp. 729-737

  3. The identification, assessment and management of difficult-to-treat depression: An international consensus statement

    Journal of Affective Disorders, Vol. 267, pp. 264-282

  4. Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice

    Schizophrenia bulletin, Vol. 46, Núm. 2, pp. 432-441

2018

  1. Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: Protocol for a phase IV, single-arm, open-label trial

    BMJ Open, Vol. 8, Núm. 10

2016

  1. Oncogenic KIT mutations in different exons lead to specific changes in melanocyte phospho-proteome

    Journal of Proteomics, Vol. 144, pp. 140-147

2015

  1. Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model

    Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3766-3773

2014

  1. Identifying gene-environment interactions in schizophrenia: Contemporary challenges for integrated, large-scale investigations

    Schizophrenia Bulletin, Vol. 40, Núm. 4, pp. 729-736